LIST OF TABLES
TABLE 01.DOSAGE AND ADMINISTRATION OF CSFS
TABLE 02.GLOBAL NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027 ($MILLION)
TABLE 03.GLOBAL NEUTROPENIA TREATMENT MARKET FOR COLONY-STIMULATING FACTOR, BY REGION, 2019-2027($MILLION)
TABLE 04.GLOBAL NEUTROPENIA TREATMENT MARKET FOR ANTIBIOTICS, BY REGION, 2019-2027($MILLION)
TABLE 05.GLOBAL NEUTROPENIA TREATMENT MARKET FOR ANTIFUNGAL, BY REGION, 2019-2027($MILLION)
TABLE 06.GLOBAL NEUTROPENIA TREATMENT MARKET FOR ANTIVIRALS, BY REGION, 2019-2027($MILLION)
TABLE 07.GLOBAL NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
TABLE 08.GLOBAL NEUTROPENIA TREATMENT MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2019-2027($MILLION)
TABLE 09.GLOBAL NEUTROPENIA TREATMENT MARKET FOR RETAIL PHARMACIES, BY REGION, 2019-2027($MILLION)
TABLE 10.GLOBAL NEUTROPENIA TREATMENT MARKET FOR ONLINE PHARMACIES, BY REGION, 2019-2027($MILLION)
TABLE 11.GLOBAL NEUTROPENIA TREATMENT MARKET, BY REGION 2019-2027, ($MILLION)
TABLE 12.NORTH AMERICA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 13.NORTH AMERICA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 14.NORTH AMERICA NEUTROPENIA TREATMENT MARKET, BY COUNTRY, 2019-2027, ($MILLION)
TABLE 15.U.S. NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 16.U.S. NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 17.CANADA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 18.CANADA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 19.MEXICO NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 20.MEXICO NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 21.EUROPE NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 22.EUROPE NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 23.EUROPE NEUTROPENIA TREATMENT MARKET, BY COUNTRY, 2019-2027, ($MILLION)
TABLE 24.GERMANY NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 25.GERMANY NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 26.FRANCE NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 27.FRANCE NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 28.UK NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 29.UK NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 30.ITALY NEUTROPENIA TREATMENT MARKET, BY TREATMETN, 2019-2027, ($MILLION)
TABLE 31.ITALY NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 32.SPAIN NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 33.SPAIN NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 34.REST OF EUROPE NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 35.REST OF EUROPE NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 36.ASIA-PACIFIC NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 37.ASIA-PACIFIC NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 38.ASIA-PACIFIC NEUTROPENIA TREATMENT MARKET, BY COUNTRY, 2019-2027, ($MILLION)
TABLE 39.JAPAN NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 40.JAPAN NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 41.CHINA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 42.CHINA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 43.AUSTRALIA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 44.AUSTRALIA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 45.INDIA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 46.INDIA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 47.REST OF ASIA-PACIFIC NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 49.LAMEA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 50.LAMEA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 51.LAMEA NEUTROPENIA TREATMENT MARKET, BY COUNTRY, 2019-2027, ($MILLION)
TABLE 52.BRAZIL NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 53.BRAZIL NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 54.SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 55.SAUDI ARABIA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 56.SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 57.SOUTH AFRICA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 58.REST OF LAMEA NEUTROPENIA TREATMENT MARKET, BY TREATMENT, 2019-2027, ($MILLION)
TABLE 59.REST OF LAMEA NEUTROPENIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2027, ($MILLION)
TABLE 60.AMGEN: COMPANY SNAPSHOT
TABLE 61.AMGEN: OPERATING SEGMENTS
TABLE 62.AMGEN: PRODUCT PORTFOLIO
TABLE 63.AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64.BEYONDSPRING : COMPANY SNAPSHOT
TABLE 65.BEYONDSPRING : PRODUCT PORTFOLIO
TABLE 66.BEYONDSPRING : KEY STRATEGIC MOVES AND DEVELOPMENT
TABLE 67.CELLERANT THERAPEUTICS : COMPANY SNAPSHOT
TABLE 68.CELLERANT THERAPEUTICS : PRODUCT PORTFOLIO
TABLE 69.CELLERANT THERAPEUTICS : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70.KYOWA KIRIN : COMPANY SNAPSHOT
TABLE 71.KYOWA KIRIN: OPERATING SEGMENTS
TABLE 72.KYOWA KIRIN : PRODUCT PORTFOLIO
TABLE 73.MYLAN: COMPANY SNAPSHOT
TABLE 74.MYLAN: OPERATING SEGMENTS
TABLE 75.MYLAN: PRODUCT PORTFOLIO
TABLE 76.MYLAN : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 77.NOVARTIS: COMPANY SNAPSHOT
TABLE 78.NOVARTIS: OPERATING SEGMENTS
TABLE 79.NOVARTIS: PRODUCT PORTFOLIO
TABLE 80.PARTNER THERAPEUTICS : COMPANY SNAPSHOT
TABLE 81.PARTNER THERAPEUTICS : PRODUCT PORTFOLIO
TABLE 82.PARTNER THERAPEUTICS : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83.PFIZER : COMPANY SNAPSHOT
TABLE 84.PFIZER : OPERATING SEGMENTS
TABLE 85.PFIZER : PRODUCT PORTFOLIO
TABLE 86.PFIZER : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 87.SPECTRUM PHARMACEUTICALS : COMPANY SNAPSHOT
TABLE 88.SPECTRUM PHARMACEUTICALS : OPERATING SEGMENTS
TABLE 89.SPECTRUM PHARMACEUTICALS : PRODUCT PORTFOLIO
TABLE 90.TEVA: COMPANY SNAPSHOT
TABLE 91.TEVA: OPERATING SEGMENTS
TABLE 92.TEVA: PRODUCT PORTFOLIO
TABLE 93.COHERUS BIOSCIENCES: COMPANY SNAPSHOT
TABLE 94.COHERUS BIOSCIENCES : OPERATING SEGMENTS
TABLE 95.COHERUS BIOSCIENCES: PRODUCT PORTFOLIO
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.SEGMENTATION OF GLOBAL NEUTROPENIA TREATMENT MARKET
FIGURE 02.PIPELINE ANALYSIS, BY COUNTRY
FIGURE 03.PIPELINE ANALYSIS, BY PHASES
FIGURE 04.PIPELINE ANALYSIS, BY YEAR
FIGURE 05.TOP WINNING STRATEGIES, BY YEAR
FIGURE 06.TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 07.TOP WINNING STRATEGIES, BY COMPANY
FIGURE 08.TOP PLAYER POSTIONING, 2019
FIGURE 09.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 10.LOW BARGAINING POWER OF BUYERS
FIGURE 11.MODERATE THREAT OF SUBSTITUTION
FIGURE 12.MODERATE THREAT OF NEW ENTRANT
FIGURE 13.MODERATE COMPETITIVE RIVALRY
FIGURE 14.GLOBAL NEUTROPENIA TREATMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF NEUTROPENIA TREATMENT MARKET FOR COLONY-STIMULATING FACTOR, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NEUTROPENIA TREATMENT MARKET FOR ANTIBIOTICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF NEUTROPENIA MARKET FOR ANTIFUNGAL, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NEUTROPENIA TREATMENT MARKET FOR ANTIVIRALS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GLOBAL NEUTROPENIA TREATMENT MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF GLOBAL NEUTROPENIA TREATMENT MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF GLOBAL NEUTROPENIA TREATMENT MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 22.U.S. NEUTROPENIA MARKET, 2020-2027 ($MILLION)
FIGURE 23.AMGEN: NET SALES, 2017-2019 ($MILLION)
FIGURE 24.AMGEN : REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 25.KYOWA KIRIN : NET SALES, 2017-2019 ($MILLION)
FIGURE 26.KYOWA KIRIN : REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.KYOWA KIRIN : REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 28.MYLAN: NET SALES, 2017-2019 ($MILLION)
FIGURE 29.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 30.NOVARTIS: NET SALES, 2017-2019 ($MILLION)
FIGURE 31.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 32.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 33.PFIZER : NET SALES, 2017-2019 ($MILLION)
FIGURE 34.PFIZER : REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.PFIZER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.SPECTRUM PHARMACEUTICALS : NET SALES, 2016-2018 ($MILLION)
FIGURE 37.SPECTRUM PHARMACEUTICALS: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 38.TEVA: NET SALES, 2017-2019 ($MILLION)
FIGURE 39.TEVA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.COHERUS BIOSCIENCES : NET SALES, 2017-2019 ($MILLION)
